Back to Search
PETER RUANE, MD
MD
Infectious Disease Physician
NPI: 1467640953Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
A42947(CA)
CMS Specialties
PrimaryINFECTIOUS DISEASE
Education
OTHER
Class of 1978
Research & Publications (20)
Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers.
PMID 17088488·Antimicrob Agents Chemother·2007
3-trial
K65R-associated virologic failure in HIV-infected patients receiving tenofovir-containing triple nucleoside/nucleotide reverse transcriptase inhibitor regimens.
PMID 15266257·MedGenMed·2004
6-review
Pharmacodynamic effects of zidovudine 600 mg once/day versus 300 mg twice/day in therapy-naïve patients infected with human immunodeficiency virus.
PMID 15040643·Pharmacotherapy·2004
3-trial
In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
PMID 18304772·Diagn Microbiol Infect Dis·2008
8-other
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
PMID 17416261·Lancet·2007
4-observational
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
PMID 17413684·AIDS·2007
3-trial
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients.
PMID 16936557·J Acquir Immune Defic Syndr·2006
3-trial
The safety and tolerability of Z-100 in patients infected with HIV-1.
PMID 16759045·Antivir Ther·2006
3-trial
Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men.
PMID 15844078·Clin Infect Dis·2005
8-other
What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2.
PMID 15457602·AIDS Read·2004
6-review
Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
PMID 15355498·Vox Sang·2004
4-observational
What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 1.
PMID 15338522·AIDS Read·2004
6-review
New nucleoside/nucleotide backbone options: a review of recent studies.
PMID 15319666·J Acquir Immune Defic Syndr·2004
6-review
Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
PMID 15157255·Transfusion·2004
4-observational
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.
PMID 14722892·J Infect Dis·2004
3-trial
Controlled photochemical release of nitric oxide from O(2)-naphthylmethyl- and O(2)-naphthylallyl-substituted diazeniumdiolates.
PMID 12392393·J Am Chem Soc·2002
8-other
Controlled photochemical release of nitric oxide from O2-benzyl-substituted diazeniumdiolates.
PMID 12175240·J Am Chem Soc·2002
8-other
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
PMID 12087139·N Engl J Med·2002
3-trial
Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.
PMID 12045491·AIDS·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5901 W OLYMPIC BLVD, SUITE # 401
LOS ANGELES, CA 90036 - Phone
- (323) 954-1072
Quick Facts
- NPI
- 1467640953
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile